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Abstract. 
 
E-selectin plays a critical role in mediating
tissue-speciﬁc homing of T cells into skin, and of primi-
tive hematopoietic progenitor cells (HPCs) into bone
marrow (BM). Though it is known that a glycoform of
PSGL-1 (CLA) functions as the principal E-selectin
 
ligand on human T lymphocytes, the E-selectin ligand(s)
of human HPCs has not been identiﬁed. We used a
shear-based adherence assay to analyze and deﬁne the
E-selectin ligand activity of membrane proteins from
human HPCs. Our data show that PSGL-1 expressed
on human HPCs is an E-selectin ligand, and that HPCs
also express a previously unrecognized E-selectin ligand,
CD44. The E-selectin ligand activity of CD44 is con-
ferred by the elaboration of sialylated, fucosylated bind-
 
ing determinants on 
 
N
 
-glycans. This glycoform of CD44
 
is expressed on primitive CD34
 
 
 
 human HPCs, but not
on more mature hematopoietic cells. Under physiologic
ﬂow conditions, this molecule mediates E-selectin–
dependent rolling interactions over a wider shear range
than that of PSGL-1, and promotes human HPC rolling
interactions on E-selectin expressed on human BM en-
dothelial cells. These ﬁndings offer new insights into the
structural biology and physiology of CD44, and into the
molecular basis of E-selectin–dependent adhesive in-
teractions that direct homing of human HPC to BM.
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Introduction
 
The selectin family of adhesion molecules consists of lec-
tins that mediate leukocyte tethering and rolling interac-
tions on endothelial cells. Their expression on either the
leukocyte (L-selectin) or endothelium (P- and E-selectin)
helps the leukocyte “slow down,” enabling cells in flow to
respond to chemokine/cytokine signals and, thus triggered,
to firmly attach to and extravasate into a tissue site. This
primary intravascular braking mechanism is controlled by
 
the Ca
 
2
 
 
 
-dependent binding activity of the selectins di-
rected against respective sialylated and fucosylated ligands
expressed on leukocytes and/or endothelial cells. Selectin-
mediated interactions are critical not only for the rapid and
efficient recruitment of leukocytes at a site of injury (Kan-
sas, 1996), but also for steady-state, tissue-specific homing
as illustrated in (a) lymphocyte homing to peripheral
lymph nodes (Kansas, 1996), (b) cutaneous tropism of hu-
man skin–homing T cells (Picker et al., 1990; Berg et al.,
1991), and (c) hematopoietic progenitor cell (HPC)
 
1
 
 entry
into bone marrow (BM) (Frenette et al., 1998; Mazo et al.,
1998; Naiyer et al., 1999). The latter two paradigms rep-
resent physiologically relevant processes that, at least in
part, are dependent on the cell-adhesive interactions be-
tween vascular E-selectin, which is
 
 
 
constitutively expressed
on postcapillary venules in the skin (Weninger et al.,
2000), and BM (Schweitzer et al., 1996) and its leukocyte
E-selectin ligands. Therefore, the cell-specific expression
of E-selectin ligands is important for understanding tissue
tropisms, but our understanding of the identity and struc-
ture of these molecules in humans is incomplete.
Rolling of human HPCs on immobilized E-selectin has
been observed in flow chamber studies, with higher effi-
ciency rolling of primitive CD34
 
 
 
 “stem” cells compared
with CD34
 
  
 
HPCs (Greenberg et al., 2000). The nature of
these E-selectin ligands on human HPCs has not been elu-
cidated. To date, the only E-selectin glycoprotein ligand
identified on HPCs is the 220-kD sialomucin-like protein,
 
Address correspondence to Robert Sackstein, Harvard Institutes of Medi-
cine, 77 Ave. Louis Pasteur, Room 671, Boston, MA 02115. Tel.: (617)
525-5601. Fax: (617) 525-5571. E-mail: rsackstein@rics.bwh.harvard.edu
 
1
 
Abbreviations used in this paper: 
 
AML, acute myelogenous leukemia;
AP, alkaline phosphatase; BM, bone marrow; BMEC-1, BM endothelial
cell line-1; CLA, cutaneous lymphocyte antigen; HA, hyaluronic acid;
 
HCELL, hematopoietic cell E-/L-selectin ligand; HPC, hematopoietic
 
progenitor cell; OSGE, O-sialoglycoprotein endopeptidase; PSGL-1,
P-selectin glycoprotein ligand 1; PVDF, polyvinylidene difluoride;
VCAM, vascular cell adhesion molecule; VLA, very late antigen. 
The Journal of Cell Biology, Volume 153, 2001 1278
 
P-selectin ligand glycoprotein 1 (PSGL-1). Notably, a pu-
tative E-selectin ligand known as ESL-1 has been de-
scribed in murine leukocytes (Steegmaier et al., 1995), but
its function and expression in human cells is uncertain.
Though PSGL-1 can function as a ligand for all three se-
lectins (Asa et al., 1995; Tu et al., 1996), the E-selectin
ligand activity of PSGL-1 depends on appropriate post-
translational glycosylation of the core protein. When deco-
rated with the relevant sialylated, fucosylated oligosaccha-
rides detected by the rat monoclonal antibody mAb
HECA-452, expression of PSGL-1 on subsets of memory
T cells confers the ability of these cells to enter cutaneous
sites through interactions with E-selectin (Picker et al.,
1990, 1991a; Rossiter et al., 1994; Fuhlbrigge et al., 1997).
Forms of PSGL-1 on T cells lacking HECA-452 epitope(s)
do not bind E-selectin, and for this reason HECA-452–
reactive carbohydrates on PSGL-1 are designated as cuta-
neous lymphocyte antigen (CLA) (Fuhlbrigge et al., 1997).
Though it is well recognized that human CD34
 
 
 
 HPCs ex-
press PSGL-1 (Zannettino et al., 1995; Levesque et al.,
1999; Sackstein and Dimitroff, 2000) and that human
CD34
 
 
 
 HPCs bind to E-selectin expressed on human BM
endothelial cells (Schweitzer et al., 1996; Naiyer et al.,
1999; Rood et al., 1999), there is neither direct evidence
that PSGL-1 on human HPCs is an E-selectin ligand, nor
any information on the identity of another potential hu-
man HPC E-selectin glycoprotein ligand(s).
Because expression of HECA-452 epitope(s) is func-
tionally correlated with E-selectin ligand activity, we
sought to determine whether glycoproteins bearing HECA-
452 antigen(s) on human HPCs could function as E-selec-
tin ligands. Using a novel blot-rolling adherence assay de-
veloped in our laboratory, we demonstrate that several
HECA-452–reactive glycoproteins expressed on human
HPCs function as E-selectin ligands. We show that human
HPCs express the CLA form of PSGL-1, and that an
HECA-452–reactive glycoform of CD44 functions as the
major E-selectin glycoprotein ligand on human HPCs. The
E-selectin binding determinants on CD44 are displayed on
sialofucosylated N-linked carbohydrates, and expression
of this structure is restricted to primitive CD34
 
 
 
 human
BM cells. Expression of this CD44 glycoform on human
HPCs promotes functional E-selectin–mediated “rolling”
interactions on primary BM microvascular endothelial
cells over a wider shear range than that of PSGL-1 alone.
These findings offer a new perspective on the biology of
CD44, and implicate a role for this molecule as a BM
“homing” receptor on primitive human HPCs.
 
Materials and Methods
 
Cells, Membrane Protein Preparation, 
SDS-PAGE, and Western Blotting
 
Human hematopoietic cell lines (KG1a, HL60, RPMI-8402, and K562)
and the BM endothelial cell line-1 (BMEC-1) (Candal et al., 1996) were
propagated in RPMI 1640/10% FBS/1% penicillin/streptomycin (Life
Technologies). Fresh circulating leukemia blasts were isolated by Ficoll-
Hypaque (1.077–1.0800 g/ml; ICN Biomedicals) density gradient centrifu-
gation from the peripheral blood of patients, where they represented
 
 
 
80% of all circulating leukocytes. Normal human BM cells were ex-
tracted from vertebral bodies of cadaveric organ donors that were ob-
tained with the consent of donor families and through the cooperation of
the New England Organ Bank. BM mononuclear cells were isolated by Fi-
 
coll-Hypaque (1.077–1.0800 g/ml) density gradient centrifugation, and
were separated into CD34
 
 
 
 and lineage
 
 
 
/CD34
 
  
 
subpopulations using
either a negative cell selection StemSep™ human progenitor enrichment
column (StemCell Technologies Inc.), or a positive selection for CD34
 
 
 
cells or other subpopulations of BM cells (monocytes [CD14
 
 
 
], granulo-
cytes [CD15
 
 
 
], B cells [CD19
 
 
 
], or T cells [CD3
 
 
 
]) by immunomagnetic
beading separation (Miltenyi Biotec). CD34
 
 
 
/CD44
 
 
 
, CD34
 
 
 
/CD44
 
 
 
,
and CD34
 
 
 
/CD44
 
 
 
 cell populations were isolated by cell sorting on a
MoFlo apparatus (Cytomation) using fluorochrome-conjugated anti-
CD34 mAb (HPCA-2) (Becton Dickinson) and anti-CD44 mAb (Her-
mes-1) (Jalkanen et al., 1986; antibody was a gift from Dr. Brenda Sand-
maier, Fred Hutchinson Cancer Research Center, Seattle, WA).
Membrane preparations of HPCs were isolated as described previously
(Sackstein and Dimitroff, 2000). For SDS-PAGE and Western blotting,
membrane preparations were diluted in reducing sample buffer and sepa-
rated on 6–9% SDS-PAGE gels. Where indicated, membrane proteins
were also treated with 
 
N
 
-glycosidase F (8 U/ml for 24 h; Roche Molecular
Biomedicals) or
 
 Vibrio cholerae
 
 neuraminidase (0.1 U/ml H/H/Ca
 
2
 
 
 
 for
1 h at 37
 
 
 
C; Roche Molecular Biochemicals) as described previously
(Sackstein and Dimitroff, 2000).
 
 
 
Resolved membrane proteins were trans-
ferred to Sequi-blot polyvinylidene difluoride (PVDF) filter membrane
(Bio-Rad Laboratories) and blocked with PBS/Tween 20/20% FBS for 1 h
at 4
 
 
 
C. Blots were incubated with rat mAb HECA-452 (1.2 
 
 
 
g/ml PBS;
PharMingen) or anti–PSGL-1 mAb 4H10 (a gift from Dr. Ray Camp-
hausen, Genetics Institute, Cambridge, MA) for 1 h at room temperature.
Isotype control immunoblots using either rat IgM or mouse IgG were per-
formed in parallel to evaluate nonspecific reactive proteins. After three
washes with PBS/0.1% Tween 20, blots were incubated with either alka-
line phosphatase (AP)-conjugated rabbit anti–rat IgM Abs (1:400) or AP-
conjugated goat anti–mouse IgG (1:8,000), depending on the primary Ab.
AP substrate, Western Blue (Promega), was then added to develop the
blots.
 
Immunoprecipitation Studies
 
Membrane protein preparations of human hematopoietic cell lines or of
normal human BM HPCs or leukemic blasts were solubilized in 2% NP-40
and precleared in Protein G Agarose (Life Technologies). Protein prepa-
rations (lysate) were incubated with anti–PSGL-1 antibody 4H10 or anti-
CD44 mAb Hermes-1 (each at 3 
 
 
 
g), or with mouse/rat IgG isotype con-
trols (3 
 
 
 
g) for 2 h at 4
 
 
 
C. The antibody–lysate mixture was added to 30 
 
 
 
l
of Protein G Agarose and incubated for 1 h at 4
 
 
 
C under constant rota-
tion. Immunoprecipitates were washed three times with lysis buffer (2%
NP-40/1% BSA), diluted in reducing sample buffer, subjected to 6 or 9%
SDS-PAGE, transferred to PVDF membrane, and immunostained with
mAbs HECA-452 or 4H10. For exhaustive immunoprecipitation of CD44,
supernatants from each round of antibody–lysate incubation were reincu-
bated with Hermes-1 (3 
 
 
 
g in each of three rounds), and immunoprecipi-
tates from each round were prepared as described above.
 
Parallel Plate Flow Chamber Studies 
Using Cell Monolayers
 
Under defined shear stress, E-selectin–mediated adhesive interactions
were examined between hematopoietic cell monolayers and suspensions
of CHO-E (CHO cells stably transfected with full-length cDNA encoding
human E-selectin) in flow. CHO-E and empty vector constructs (mock-
transfected CHO cells [CHO-Mock]) were maintained in MEM with 10%
FBS and 1% penicillin/streptomycin (Life Technologies), and HAM’s
F-12 with 5% FCS and 1% penicillin/streptomycin, respectively (Cellgro,
Inc.) CHO-E cell tethering and rolling on hematopoietic cell monolayers
was visualized by video microscopy in real time using the parallel plate
flow chamber. Before experimentation, CHO-E cells were harvested with
5 mM EDTA, washed twice in HBSS, and suspended at 10
 
7
 
/ml in HBSS/
10 mM Hepes/2 mM CaCl
 
2
 
 (H/H/Ca
 
2
 
 
 
). Negative control groups were
prepared by adding either 5 mM EDTA to the H/H assay buffer (to che-
late Ca
 
2
 
 
 
 required for binding), treating CHO-E cells with anti–E-selectin
Abs (clone 68-5H11) (10 
 
 
 
g/ml; BD PharMingen), or using CHO-empty
vector transfectants (CHO-mock). To prepare hematopoietic cell mono-
layers 
 
 
 
90% confluent, suspensions of cells (KG1a, HL60, K562, or
RPMI 8402) at 2 
 
 
 
 10
 
6
 
/ml RPMI 1640 without sodium Bicarbonate/2%
FBS were cytocentrifuged in 6-well plates at 5 
 
 
 
 10
 
6
 
/well, and then fixed
in 3% glutaraldehyde. Reactive aldehyde groups were blocked in 0.2 M
lysine and plated cells were suspended in H/H/Ca
 
2
 
 
 
. In parallel, cells were
also pretreated with either 
 
V. cholerae 
 
neuraminidase (0.1 U/ml in H/H/ 
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Ca
 
2
 
 
 
 
 
for 1 h at 37
 
 
 
C) or O-sialoglycoprotein endopeptidase (OSGE) (60
 
 
 
g/ml in H/H/Ca
 
2
 
 
 
 
 
for 1 h at 37
 
 
 
C; Accurate Chemicals), respectively.
Cell monolayers were placed in the parallel plate flow chamber and CHO-
E/-mock cells were perfused into the chamber. After allowing the CHO-E
or CHO-mock cells to come into contact with the cell monolayers, the
flow rate was adjusted to exert shear stress of 2.8 dyn/cm
 
2
 
. The number of
CHO-E/-mock cell rolling on each monolayer was measured in one frame
of five independent fields under 100
 
 
 
 magnification from multiple experi-
ments. A minimum of three experiments was performed and results were
expressed as the mean 
 
  
 
SD.
Alternately, using freshly isolated human primary BMECs cultured as
previously described (Rafii et al., 1994), BMECs from subcultures not
older than passage 5 were seeded at 10
 
5 
 
cells/well in 6-well plates, and
when 90–100% confluent, were stimulated with IL-1
 
 
 
 (40 U/ml) for 4 h to
upregulate the surface expression of E-selectin (expression of which was
measured by flow cytometric analysis). Live cultures were then placed in
the parallel plate flow chamber and hematopoietic cells (10
 
7
 
/ml in H/H/
Ca
 
2
 
 
 
) were perfused into the chamber over the BMECs. Hematopoietic
cell tethering and rolling was visualized at 2.8 dyn/cm
 
2
 
. Non–IL-1
 
 
 
–acti-
vated BMECs and IL-1
 
 
 
–activated BMECs treated with 10 
 
 
 
g/ml anti–
E-selectin mAb (clone 68-5H11) served as controls for assessing specific-
ity of E-selectin–mediated adhesion. Cellular rolling was quantified and
expressed as described above.
 
Using Immobilized Immunoprecipitates 
 
CD44 was immunoprecipitated from untreated cell lysates or from cell ly-
sates treated with 
 
N
 
-glycosidase F (8 U/ml), 
 
V. cholerae
 
 neuraminidase
(0.1 U/ml), or 
 
 
 
-
 
L
 
-fucosidase (80 m U/ml), and PSGL-1 was immunopre-
cipitated from untreated cell lysates as described previously (Dimitroff et
al., 2000; Sackstein and Dimitroff, 2000). CD44 or PSGL-1 immunoprecip-
itates were spotted onto plastic Petri dishes, fixed in 3% glutaraldehyde,
and incubated in 0.2 M lysine to block unreactive aldehyde groups, and
nonspecific binding was prevented by incubating in 100% FBS for 1 h at
room temperature. Where indicated, fixed spots were also treated with 
 
V.
cholerae
 
 neuraminidase (0.1 U/ml assay medium), which was overlaid
onto the spots and incubated at 37
 
 
 
C for 1 h. The protein dishes were
placed in the parallel plate flow chamber and CHO-E, CHO-P (CHO sta-
bly transfected with human cDNA encoding full- length P-selectin), CHO-P
cells treated with function-blocking anti–P-selectin mAb (clone AK-4) (10
 
 
 
g/ml; BD PharMingen), CHO-E cells treated with function-blocking
anti–E-selectin Abs (clone 68-5H11; 10 
 
 
 
g/ml), or mock transfectants
were perfused into the chamber (2 
 
  
 
10
 
6
 
/ml H/H/Ca
 
2
 
 
 
) at a flow rate of
0.2 ml/min until the cells were in contact with the substrate. The flow rate
was then increased to achieve a shear stress of 2.8 dyns/cm
 
2
 
. The fre-
quency of cells rolling per 100
 
  
 
magnification field was determined, and
data were expressed as the mean 
 
 
 
 SD of eight fields visualized from a
minimum of three experiments.
 
Blot Rolling Assay
 
This blot rolling assay has been described previously (Dimitroff et al.,
2000). In brief, CHO-E, CHO-P, or CHO-mock cells were isolated as de-
scribed above, washed twice in HBSS, and suspended at 10
 
7
 
/ml in HBSS/
10 mM Hepes/2 mM CaCl
 
2
 
 (H/H/Ca
 
2
 
 
 
)/10% glycerol. Western blots of
HPC membrane preparations stained with HECA-452 were rendered
transparent by incubating them in H/H/Ca
 
2
 
 
 
/10% glycerol. These blots
were then placed in the parallel plate flow chamber, and CHO transfec-
tants (2 
 
  
 
10
 
6
 
/ml) were perfused into the chamber. After allowing the
cells to come in contact with the blotting membrane, the flow rate was ad-
justed to exert a shear stress of 3.8 dyn/cm
 
2
 
. The viscosity of 10% glycerol
adhesion assay medium was considered in our calculation of shear stress
values. The number of cells rolling on and between each immunostained
banding region was quantified under 100
 
  
 
magnification within each field
of view on the video monitor using Kaleidoscope Molecular Weight
Markers (Bio-Rad Laboratories) and See Blue
 
®
 
 (Novex, Inc.) as guides to
help align and visualize the apparent molecular weights of the proteins of
interest. A minimum of three experiments was performed, and results
were expressed as the mean 
 
  
 
SD of cell rolling per field at 100 
 
 
 
 magni-
fication. Negative controls were prepared by either adding 5 mM EDTA
to the CHO-E H/H assay buffer to chelate Ca
 
2
 
 
 
 required for binding, pre-
treating CHO-E cells with anti–E-selectin Abs (clone 68-5H11; 10 
 
 
 
g/ml),
or by assessing the ability of CHO-mock cells to interact with the immobi-
lized proteins.
 
Results
 
SDS-PAGE and Western Blot Analysis of 
HECA-452–reactive Membrane Glycoproteins 
on Human Hematopoietic Cells
 
SDS-PAGE and Western blot analysis of HECA-452–
reactive epitope(s) were performed on membrane pro-
teins from various human hematopoietic cell lines (KG1a,
HL60, RPMI-8402, and K562). As illustrated in Fig. 1 A,
numerous and distinct HECA-452–reactive bands were
detected on SDS-PAGE of membrane protein isolated
from KG1a cells. Despite 10-fold less KG1a membrane
protein loaded for analysis in these blots compared with
that of HL60, RPMI-8402, or K562 cellular membrane
protein, KG1a cells contained markedly more HECA-452
staining displayed on several component protein bands.
Only one broad band of 
 
 
 
140 kD was detected on HL60
cells, which corresponded to the monomer species of
PSGL-1 by immunoblot (Fig. 1 A) (Fuhlbrigge et al.,
1997). There were no HECA-452–reactive membrane pro-
teins from RPMI-8402 or K562 cells, even though PSGL-1
was detected on Western blots of these cells by using the
anti–PSGL-1 antibody, 4H10 (Dimitroff et al., 2000). This
finding suggested that these cells lacked the appropriate
HECA-452–binding epitope and, at minimum, the E-selec-
tin–binding species of PSGL-1.
 
Parallel Plate Flow Analysis of E-Selectin Ligand 
Activity of Human Hematopoietic Cells
 
To examine whether HECA-452 expression by human he-
matopoietic cell lines correlated with E-selectin ligand ac-
tivity, parallel plate flow chamber studies were performed
to assess E-selectin binding under defined shear flow con-
ditions. Tethering and rolling of CHO-E cells was ob-
served on glutaraldehyde-fixed monolayers of KG1a and
HL60 cells at 2.8 dynes/cm
 
2
 
 (Fig. 1 B). CHO-mock cells
displayed no rolling. CHO-E cell rolling was twofold
higher on KG1a cells than on HL60 cells, and was com-
pletely inhibited by adding 5 mM EDTA to the assay me-
dium, by preincubating CHO-E cells with anti–E-selectin
Abs, or by pretreating KG1a or HL60 cells with 
 
Vibrio
cholerae
 
 neuraminidase (which cleaves terminal sialic ac-
ids). There was no E-selectin ligand activity on cell lines
RPMI-8402 and K562, whose membrane proteins did not
contain HECA-452 epitopes. These findings confirm pre-
vious reports that E-selectin ligand activity of PSGL-1
requires the expression of HECA-452–reactive posttrans-
lational modifications (Fuhlbrigge et al., 1997). Interest-
ingly, the E-selectin ligand activity of KG1a and HL60
cells was not inhibited by incubating cells with HECA-452
at 50 
 
 
 
g/ml, and was not abrogated by pretreatment with
OSGE (Fig. 1 B), though OSGE bioactivity was con-
firmed by the disappearance of the OSGE-sensitive epi-
tope, QBEND-10, on KG1a CD34 as measured by flow
cytometry.
To analyze the interaction between human HPCs and
naturally expressed E-selectin on cells of physiologic im-
portance, we used freshly isolated human BMEC for par-
allel plate flow chamber studies. Under physiologic shear
flow conditions, we observed KG1a and HL60 cell rolling 
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on live monolayers of IL-1
 
 
 
–activated BMECs. Consistent
with results from experiments using CHO-E cells to assess
HPC E-selectin ligand activity, KG1a cells possessed a four-
fold greater capacity to roll on E-selectin on IL-1
 
 
 
–acti-
vated BMECs than HL60 cells, while RPMI-8402 and
K562 cells possessed minimal E-selectin ligand activity
(Fig. 2). KG1a and HL60 cellular E-selectin ligand activi-
ties were not observed on non–IL-1
 
 
 
–activated BMECs,
or on IL-1
 
 
 
–activated BMECs treated with a functional-
blocking anti–E-selectin mAb.
 
Blot Rolling Assay of E-Selectin Glycoprotein 
Ligands from Human Hematopoietic Cells
 
To examine the E-selectin ligand activity of all HECA-452–
reactive KG1a membrane proteins, we used a new method
for assessing the adhesive interactions under shear flow be-
 
tween selectin-expressing whole cells and proteins immobi-
lized on Western blots (Dimitroff et al., 2000). Membrane
proteins were separated on 6% SDS-PAGE gel, trans-
ferred onto PVDF membrane, and then stained with
HECA-452. Component membrane proteins were analyzed
for their ability to support CHO-E cell rolling under de-
fined hydrodynamic flow conditions. We reproducibly ob-
served E-selectin ligand activity on HECA-452–stained
bands at 100, 120, 140, 190, and 220 kD, but not at 74 kD
(Fig. 3 A). CHO-mock cells showed no interactions with
any bands. Specificity for E-selectin was demonstrated by
the abrogation of CHO-E cell rolling in the presence of ei-
ther 5 mM EDTA or anti–E-selectin functional blocking
Abs. On HL60 cells, CHO-E cell rolling was observed only
over the broad 140-kD HECA-452–immunostained band
(i.e., PSGL-1/CLA) (data not shown). To determine whether
E-selectin–binding determinants reside on 
 
N
 
-glycans, we
treated KG1a membrane protein with 
 
N
 
-glycosidase F.
De–
 
N
 
-glycosylated proteins were resolved by SDS-PAGE
and analyzed for HECA-452 reactivity and E-selectin
ligand activity. 
 
N
 
-glycosidase F treatment markedly dimin-
ished HECA-452 staining (Fig. 3 B) and completely abol-
ished CHO-E cell rolling on all proteins on the blot, indi-
cating that all glycoprotein E-selectin binding determinants
on KG1a cells are displayed exclusively on 
 
N
 
-glycans.
Figure 1. Expression of HECA-452–reactive glycoproteins on
human hematopoietic cells and E-selectin ligand activity of hu-
man hematopoietic cell lines. (A) Membrane preparations of hu-
man hematopoietic cell lines, KG1a (10  g), HL60 (100  g),
RPMI-8402 (100  g), and K562 (100  g) were resolved on a re-
ducing 6% SDS-PAGE gel and immunoblotted with HECA-452.
(B) Parallel plate flow chamber analysis of CHO-E cell tethering
and rolling on glutaraldehyde-fixed monolayers of hematopoietic
cell lines (shear stress of 2.8 dynes/cm2). Twofold more CHO-E cell
tethering and rolling was observed on KG1a than on HL60 cell
monolayers, which was not affected by OSGE pretreatment.
There was no CHO-E cell rolling on RPMI-8402 or K562 cell
monolayers. Negative controls consisted of CHO-mock transfec-
tants and CHO-E cells treated with anti–E-selectin Abs (10  g/
ml). Data are presented as mean   SD CHO-E cell rolling per
field   5 fields, minimum of three experiments.
Figure 2. Human hematopoietic cell rolling on freshly isolated
human BMEC. KG1a, HL60, RPMI-8402, and K562 were per-
fused over live IL-1 –treated primary BMEC cultures at 2.8
dynes/cm2 in the parallel plate flow chamber, and cell rolling was
observed and recorded for video analysis. Controls consisted of
untreated BMEC and IL-1 –treated BMEC in the presence of
anti–E-selectin mAb. Untreated BMEC showed no E-selectin
ligand activity, and rolling on IL-1 –treated BMEC was elimi-
nated by incubation with function-blocking anti–E-selectin mAb
68-5H11. Data represent mean   SD cell rolling frequency per
100   magnified field   5 fields of view, minimum of three ex-
periments. Note that KG1a cell rolling was 3.5-fold greater than
that of HL60 cells.Dimitroff et al. HCELL Is a Human Bone Marrow Homing Receptor 1281
To distinguish KG1a cellular PSGL-1/CLA from the
other HECA-452–reactive bands, we immunostained blots
of immunoaffinity-purified PSGL-1 and of total KG1a
membrane protein with either HECA-452 or anti-PSGL-1
(Fig. 3 C). We found that KG1a cells express both the
monomer and dimer isoforms of PSGL-1, which repre-
sented the 140- and 220-kD HECA-452–reactive proteins
(Fig. 3 C). Thus, the HECA-452–reactive bands at 100,
120, and 190 kD, which support CHO-E cell rolling (Fig. 3
A), corresponded to non–PSGL-1 proteins. Recent data
from our laboratory show that HECA-452–reactive mem-
brane proteins at 100, 120, and 190 kD from Western blots
of KG1a cells represent isoforms of CD44 (Dimitroff et
al., 2000). Accordingly, to directly analyze whether N-gly-
can–specific modifications of CD44 confer E-selectin
ligand activity, we immunoaffinity-purified CD44 from
KG1a membrane proteins and tested its capacity to serve
as an E-selectin ligand in blot rolling assays. As shown in
Fig. 3 D, KG1a CD44 showed HECA-452 reactivity and
possessed E-selectin ligand activity. Treatment of CD44
with N-glycosidase F markedly reduced HECA-452 reac-
tivity and completely abrogated CHO-E cell rolling (Fig. 3
D). Exhaustive immunoprecipitation of CD44 (three
rounds) resulted in the disappearance of stainable CD44
molecule at 100 kD (Hermes-1 immunoblot and HECA-
452 immunoblot) and of all E-selectin ligand activity at the
Figure 3. HECA-452–reactive CD44 functions as an E-selectin ligand. (A) KG1a membrane protein (10  g) was resolved on a reduc-
ing 6% SDS-PAGE gel, blotted onto PVDF membrane, stained with HECA-452, and HECA-452 immunoblots blots were rendered
transparent with 10% glycerol. CHO-E cells (2   106/ml) were then perfused over these blots at a defined shear stress of 3.8 dynes/cm2.
Several HECA-452–stained bands from KG1a membrane protein–supported, E-selectin–dependent CHO-E cell rolling. (B) KG1a
membrane proteins (10  g) were treated with N-glycosidase F, separated on a reducing 6% SDS-PAGE gel, and immunostained with
HECA-452. (C) Immunoprecipitated PSGL-1 was resolved on a reducing 6% SDS-PAGE gel and Western blotted with either HECA-
452 (left) or anti–PSGL-1 antibody 4H10 (right). (lane 1) 10  g of total KG1a membrane protein; (lane 2) immunoprecipitated PSGL-1
from 100  g of KG1a membrane protein; (lane 3) 100  g of total KG1a membrane protein, and (lane 4) immunoprecipitated PSGL-1,
from 100  g of KG1a membrane protein. Note that HECA-452–stained bands at 140 and 220 kD correspond to PSGL-1. (D) Isotype
control or Hermes-1 immunoprecipitated CD44 from KG1a membrane protein (50  g) was resolved on a reducing 9% SDS-PAGE gel
and immunoblotted with HECA-452. Immunoprecipitated CD44 from KG1a membrane proteins (50  g) treated with N-glycosidase F
was also immunoblotted with HECA-452. Though CHO-E cell rolling frequencies are presented as the mean   SD of E-selectin–medi-
ated cell rolling at 3.8 dynes/cm2 measured on the 100-kD isoform of CD44, no CHO-E rolling was observed along the entire length of
the N-glycosidase F–treated lane.The Journal of Cell Biology, Volume 153, 2001 1282
100-kD and 190-kD bands (Fig. 4, A and B). Moreover,
there was a 55% decrement in E-selectin ligand activity at
the 120-kD band after three rounds of immunoprecipita-
tion (Fig. 4 B). Notably, there was no difference in HECA-
452 staining or in E-selectin ligand activity of the 140-kD
monomer species of PSGL-1 after removal of CD44.
Analysis of E-Selectin Ligand Activities of PSGL-1 and 
CD44 Isolated from Human Hematopoietic Cells
To further explore the E-selectin ligand activity of CD44,
we directly immunoprecipitated CD44 from human he-
matopoietic cell lines and analyzed CHO-E cell binding in
the parallel-plate flow chamber. While CD44 isolated
from human hematopoietic cell lines HL60, K562, and
RPMI-8402 did not support any CHO-E cell rolling, KG1a
CD44 exhibited E-selectin ligand activity over a range of
shear stress. Significantly greater CHO-E cell rolling was
observed on untreated KG1a CD44 than on N-glycosidase
F, on an  -L-fucosidase–treated KG1a CD44, on V. chol-
erae neuraminidase–treated KG1a membrane protein or
on isotype Ab immunoprecipitates (control) (Fig. 5 A). In
addition, compared with a molecular equivalent amount of
immunoprecipitated KG1a PSGL-1, CD44 showed mark-
edly greater E-selectin ligand activity at 2.8 dynes/cm2 (P  
0.001) (Fig. 5 A). However, at a lower shear stress of 0.6
dynes/cm2, CHO-E cell rolling on PSGL-1 was equivalent
to that of CD44. These data suggest that PSGL-1 and
CD44 have overlapping contributions to E-selectin bind-
ing at low shear stress, but that CD44 engagement with
E-selectin predominates at higher physiologic shear stress.
Notably, CHO cells transfected with P-selectin rolled on
KG1a PSGL-1, but not on KG1a CD44 (Fig. 5 B), indicat-
ing that CD44 is not a P-selectin ligand (Fig. 5 B). In all ex-
periments, negative control CHO cells (CHO-mock cells
and CHO-E or CHO-P cells treated with function-block-
ing anti–E- or anti–P-selectin mAbs, respectively) did not
tether and roll on any proteins.
Analysis of E-Selectin Ligand Activity of CD44 from 
Native Human Hematopoietic Progenitor Cells
To determine whether CD44 naturally expressed on nor-
mal human HPCs functions as an E-selectin ligand, we in-
vestigated the distribution of HECA-452 reactivity and
E-selectin ligand activity of CD44 expressed on early
CD34  cells and more mature (CD34 /lineage ) human
BM cells (including populations enriched for monocytes
[CD14 ]), granulocytes [CD15 ], and lymphocytes (B
cells [CD19 ] and T cells [CD3 ]). Notably, though SDS-
PAGE of Hermes-1 immunoprecipitates of KG1a cells re-
veals three bands (100, 120, and 190 kD), only a single 100-
kD CD44 was immunoprecipitated from both CD34  and
lineage /CD34  cells, and only CD44 from CD34  cells
stained with HECA-452 and functioned as an E-selectin
ligand (Fig. 6 A). Identical results were obtained whether
CD34  cells were enriched by negative or positive selec-
tion. Indeed, even when tenfold excess lineage  cell mem-
brane protein was used for CD44 immunoprecipitation,
there was still neither HECA-452 staining of CD44, nor
E-selectin ligand activity of CD44 (Fig. 6 A). Moreover,
immobilized on plastic, CD44 immunoprecipitated only
from CD34 /CD44  cells supported CHO-E cell rolling,
whereas immunoprecipitated CD44 from CD34  cells did
not possess any E-selectin ligand activity.
To further analyze the expression and structure of
HECA-452–reactive CD44 on human hematopoietic cells,
we evaluated whether native leukemic blasts displayed
this CD44 glycoform. Four major HECA-452 stained
bands were detected (74, 100, 140, and 190 kD) from leu-
kemic blasts of an acute myelogenous leukemia (AML)
(subtype M5) (Fig. 6 B). HECA-452 staining was com-
pletely eliminated in the 100-kD region following N-gly-
cosidase F treatment, while the 74- and 140-kD bands had
persistent staining and the 190-kD band stained at an ap-
parently reduced molecular weight (Fig. 6 B). When im-
munoprecipitated CD44 from AML (M5) membrane pro-
tein was treated with N-glycosidase F, the HECA-452
reactivity as well as the E-selectin ligand activity was com-
Figure 4. Exhaustive immunoprecipitation of CD44 (Hermes-1)
and blot rolling assay of residual E-selectin ligand activity. Her-
mes-1 immunoblot (A) or HECA-452 immunoblot ( B) of KG1a
lysate (10  g) subjected to three rounds of immunoprecipitation
with Hermes-1 mAb. (Pre-Ippt) Total KG1a lysate 10  g; (lane 1)
first round Hermes-1 immunoprecipitate; (lane 2) second round
Hermes-1 immunoprecipitate; (lane 3) third round Hermes-1 im-
munoprecipitate; (lane 4)  residual lysate  after three rounds of
Hermes-1 immunoprecipitation. E-selectin ligand activity (CHO-E
cell rolling) correlates with intensity of the Hermes-1 staining and
of HECA-452 staining of 100-kD band, is reduced after each
round of Hermes-1 immunoprecipitation (A), and was com-
pletely absent in the residual lysate material after the third round
of immunoprecipitation (lane 4, A and B). CHO-E cell rolling
was also eliminated over the 190-kD band by exhaustive Hermes-1
immunoprecipitation, whereas CHO-E cell rolling on 120-kD
stained band was markedly reduced, and the 140-kD band
(PSGL-1) retained full activity (B, lane 4).Dimitroff et al. HCELL Is a Human Bone Marrow Homing Receptor 1283
pletely abolished (Fig. 6 C). Similar to immunoprecipi-
tated KG1a CD44, AML (M5) CD44 displayed a minor
isoform at 120 kD detected by HECA-452, but the major
band and biologically active protein was the 100-kD CD44
isoform. CD44 was also immunoprecipitated from blasts
of an undifferentiated AML (M0), an AML without matu-
ration (M1), and an atypical chronic myelogenous leuke-
mia (bcr/abl ). Notably, expression of the HECA-452–
reactive epitopes on immunoprecipitated CD44 directly
correlated with the ability to support CHO-E cell rolling
(Fig. 6 D). The expression of CD44 (Hermes-1 mAb) on
these leukemias was equivalent ( 90% positive cell stain-
ing by flow cytometry), further indicating that the ability
to interact with E-selectin was dependent on the elabo-
ration of HECA-452–reactive glycosylations. Moreover,
since CD44 is also expressed on nonhematopoietic cells,
we analyzed CD44 expressed on the human BM endothe-
lial cell line BMEC-1. Though BMEC-1 expressed high
levels of CD44 (Fig. 6 E), CD44 from these cells was not
HECA-452 reactive and did not possess any E-selectin
ligand activity (Fig. 6 D).
Discussion
In contrast to its usual pattern of inducible expression,
E-selectin is constitutively expressed on dermal and BM
microvascular endothelium, indicating that selective tro-
pism(s) of circulating cells to these tissues is regulated by
expression of cell-specific E-selectin ligands. The goal of
this study was to identify E-selectin ligands expressed on
human HPCs that could function in mediating HPC hom-
ing to BM. Earlier studies of E-selectin ligands expressed
on mature human leukocytes showed that expression of the
HECA-452 epitope(s) on lymphocyte PSGL-1 and on neu-
trophil L-selectin correlates with E-selectin binding capa-
bility (Picker et al., 1991b; Fuhlbrigge et al., 1997; Zöllner
et al., 1997). Similarly, in the mouse, HECA-452 decora-
tion of the neutrophil E-selectin ligand, ESL-1, was found
to predict E-selectin ligand activity (Zöllner and Vestwe-
ber, 1996). Since expression of HECA-452 epitope(s) is
functionally correlated with E-selectin ligand activity of
glycoproteins expressed on mature leukocytes, we sought
to determine whether HECA-452–reactive glycoproteins
on human HPCs could function as E-selectin ligands.
To analyze the E-selectin ligand activity of human he-
matopoietic cells, we performed parallel-plate flow cham-
ber studies of CHO-E cell tethering and rolling on he-
matopoietic cells lines and of hematopoietic cell rolling on
naturally expressed E-selectin on IL-1 –stimulated pri-
mary BM endothelial cultures. The data presented here
show that KG1a and HL60 cells, and not RPMI-8402 or
K562 cells, possess E-selectin ligand activity. The E-selec-
tin–mediated adhesive interactions between these he-
matopoietic cell lines and CHO-E cells parallel results of
binding studies using primary BM endothelial cells, dem-
onstrating the utility and fidelity of CHO-E as a cellular
reagent to detect and analyze E-selectin ligands. Consis-
tent with results from these binding studies, Western blot
analysis of HECA-452 epitope(s) revealed that KG1a and
HL60 membrane proteins display HECA-452–reactive
glycoproteins, whereas RPMI-8402 and K562 membrane
proteins do not. The major HECA-452–reactive mem-
brane glycoprotein(s) of HL60 cells consist of the mono-
mer (140 kD) form of PSGL-1, however, KG1a cells pos-
sess multiple HECA-452–reactive glycoproteins at MW of
74, 100, 120, and 190 kD in addition to the 140-kD and
220-kD (dimer) PSGL-1 bands.
Using the hydrodynamic shear-based blot rolling assay
to investigate the E-selectin ligand activity of HL60 and
KG1a membrane glycoproteins, we show here that the
HECA-452–reactive PSGL-1 expressed on these cells func-
tions as an E-selectin ligand. Additionally, with the excep-
tion of the 74-kD glycoprotein, HECA-452–reactive glyco-
proteins each exhibit E-selectin ligand activity on KG1a
cells at 100, 120, and 190 kD. The absence of CHO-E–bind-
Figure 5. HECA-452–reactive CD44 is a more avid E-Selectin
ligand than PSGL-1. Equivalent amounts (1  g) of either immu-
noprecipitated CD44 or PSGL-1 were analyzed for E-selectin
and P-selectin ligand activity in the parallel plate flow chamber.
(A) E-selectin–mediated CHO-E cell rolling was observed at 2.8
dynes/cm2 on KG1a CD44, but was significantly lower on KG1a
PSGL-1 at 2.8 dynes/cm2 (P   0.001). N-glycosidase F- and  -L-
fucosidase-treated KG1a CD44, and Vibrio cholerae neuramini-
dase treatment of KG1a membrane protein abrogated CHO-E
cell rolling (P   0.001), and no CHO-E cell rolling was observed
on isotype control rat IgG– or mouse IgG–immunoprecipitated
KG1a protein (data not shown). (B) CHO-P cell rolling was ob-
served on KG1a PSGL-1 but not on KG1a CD44 (2.8 dyn/cm2).
No rolling was observed on negative controls (CHO-Mock cells
and CHO-P cells pretreated with function-blocking anti–P-selec-
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ing interactions by the 74-kD HECA-452 reactive protein
indicates that the presence of the HECA-452 epitope does
not, in itself, confer E-selectin ligand activity. Moreover,
the observations that HECA-452 staining of immunoblots
did not block CHO-E cell binding to relevant glycopro-
teins, and that HECA-452 incubation of KG1a cells and
HL60 cells did not inhibit rolling on BMEC or CHO-E
binding to the cells, indicate that the HECA-452 epitope is
not the direct binding determinant for E-selectin.
The data obtained from blot rolling assays of Hermes-
1–immunoprecipitated KG1a membrane proteins demon-
strate that the E-selectin ligand activity at 100 and 190 kD
Figure 6. HECA-452–reactive CD44 from freshly isolated nor-
mal human HPCs and from human leukemic blasts functions as
an E-selectin ligand. (Panel A) HECA-452 staining of CD44 im-
munoprecipitated from (a) human BM mononuclear cells (108
cells), (b) CD34 /lineage  cells (107 cells), (c) CD34 /lineage 
cells (107 cells), (d) CD34 /lineage  cells (108 cells). HECA-452
staining of CD44 and CHO-E cell rolling was observable only on
the 100-kD CD44 immunoprecipitated from CD34 /lineage 
cells (data are mean   SD cell rolling/field on the 100-kD band).
(B) Membrane proteins (50  g) isolated from circulating blasts
from an AML (M5) were resolved on a 9% SDS-PAGE gel and
immunoblotted with HECA-452. Treatment of membrane pro-
teins with N-glycosidase F markedly diminished HECA-452
staining. (C) Blot rolling assay results of AML (M5) membrane
protein (50  g) immunoprecipitated with isotype control or with
Hermes-1 mAb, and of N-glycosidase F–treated Hermes-1 immu-
noprecipitates. Though data shown in parentheses is CHO-E cell
rolling over the 100-kD band, no rolling was observed over the
entire length of the lane corresponding to N-glycosidase F–treated
protein. (D) Immunoprecipitated CD44 from membrane prepa-
rations (50  g) of an AML (M0), AML (M1) and atypical CML
(brc/abl ), and of human BMEC line (BMEC-1; 100  g total pro-
tein), was separated on a 6% SDS-PAGE gel, immunostained with HECA-452, and evaluated for E-selectin ligand activity. E-selectin
ligand activity correlates with intensity of HECA-452 staining of 100-kD band. (E) Western blot of immunoprecipitated CD44 from
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is solely due to CD44, and that CD44 is the major contrib-
utor of the E-selectin ligand activity at 120 kD. The resid-
ual E-selectin ligand activity observed at 120 kD following
exhaustive Hermes-1 immunoprecipitation of KG1a ly-
sates may reflect the minor contribution of a non–CD44
E-selectin ligand, or, less likely, of a CD44 isoform lacking
the Hermes-1 epitope. The E-selectin–binding, HECA-
452–reactive glycoform of CD44 is also expressed on the
CD34  progenitor cell subset of normal human BM
mononuclear cells and on blasts from some de novo hu-
man leukemias, but is not present on more mature
(lineage ) BM cells, including those enriched for subpop-
ulations consisting of monocytes, granulocytes, and lym-
phocytes.
Blot rolling assays of HECA-452 immunoblots of KG1a
membrane protein show that the cumulative E-selectin
ligand activity of HECA-452–reactive CD44 (100-, 120-,
and 190-kD bands) was markedly greater than that repre-
sented by PSGL-1 (140 and 220 kD), and reveal that the
predominant E-selectin ligand of human hematopoietic
cells is the 100-kD CD44 band. This 100-kD form of CD44
corresponds to the “standard” hematopoietic form of
CD44 (Stamenkovic et al., 1991), and it is the only form
immunoprecipitated from normal human BM cells (Fig. 6
A). Since this molecule is also an L-selectin ligand (Dim-
itroff et al., 2000), we now designate this structure as he-
matopoietic cell E-/L-selectin ligand (HCELL). However,
unlike PSGL-1, which binds all three selectins, HCELL is
not a ligand for P-selectin. Compared with PSGL-1, in flow
chamber assays (a) HCELL/CD44 E-selectin binding was
significantly higher at 2.8 dynes/cm2 and functioned over a
wider range of shear stress, and (b) HCELL/CD44 expres-
sion conferred a greater capacity of human hematopoietic
cells to roll on E-selectin naturally expressed on BM mi-
crovasculature under physiologic shear stress conditions.
These data show that HCELL is a major glycoprotein
ligand on human HPCs and suggest that engagement of
HPCs with E-selectin at a physiologic postcapillary venule
shear stress level is mediated preferentially by HCELL.
Sialidase and fucosidase treatment each abrogated E-selec-
tin–binding activity of CD44, highlighting the importance of
sialic acid and fucose modifications for creation of the selec-
tin binding determinant. Elimination of ligand activity fol-
lowing N-glycanase digestion of KG1a membrane protein
indicates that these critical sialofucosylated modifications
are displayed on N-glycosylations, whereas the insensitivity
to OSGE digestion suggests that the relevant glycosylations
for E-selectin binding of HCELL are not clustered on ex-
tensively O-glycosylated peptide regions (Steininger et al.,
1992). Our data showing that CD44 lacking HECA-452 did
not possess E-selectin ligand activity is consistent with re-
sults from prior studies showing that HECA-452–nonreac-
tive CD44 from human tonsils does not exhibit E-selectin
ligand activity (Berg et al., 1991). Thus, CD44, a molecule
principally known for its capacity to bind extracellular ma-
trix molecules such as hyaluronic acid (HA) (Aruffo et al.,
1990), requires critical sialylated and fucosylated carbohy-
drate modifications to function as HCELL. Of interest, sial-
ylation of CD44 has been shown to inhibit binding to HA
(Skelton et al., 1998; Katoh et al., 1999), which may explain
the finding that though human CD34  BM cells character-
istically express high levels of CD44 (Kansas et al., 1990;
Peled et al., 1999), an unexpectedly small fraction of these
cells bind to HA (Peled et al., 1999).
Previous studies have shown that human HPCs possess
E-selectin ligand(s) (Naiyer et al., 1999; Peled et al., 1999;
Greenberg et al., 2000) and that human HPC interactions
with human BMECs under shear conditions are mediated
principally by E-selectin receptor/ligand interactions (Schweit-
zer et al., 1996; Rood et al., 2000), but the human HPC
E-selectin ligand(s) have not been identified heretofore.
In the mouse, intravital microscopy studies have demon-
strated that E-selectin, which is constitutively expressed
on murine BM microvasculature in vivo, can mediate HPC
rolling interactions and that adhesive interactions between
very late antigen (VLA)-4 expressed on HPCs and BM en-
dothelium vascular cell adhesion molecule (VCAM)-1
also mediate rolling interactions (Mazo et al., 1998). How-
ever, even though IL-1  stimulation of primary BMEC
cultures markedly upregulates the expression of VCAM-1
(Rafii et al., 1994) and despite high VLA-4 expression on
KG1a and HL60 cells (Oxley and Sackstein, 1994), rolling
of KG1a or HL60 cells on primary BMECs did not utilize
the VLA-4/VCAM-1 receptor–ligand pair, as evidenced
by the complete abrogation of rolling interactions by anti–
E-selectin mAb treatment alone. This finding is consistent
with prior reports showing that VCAM-1 in the absence of
SDF-1 is incapable of supporting CD34  adhesive inter-
actions on BM endothelium under flow (Peled et al., 1999;
Schweitzer et al., 1996; Rood et al., 2000), further high-
lighting the importance of E-selectin in this process.
The broad expression of the triselectin ligand PSGL-1
(and of VLA-4) among both immature and mature nucle-
ated hematopoietic cells raises the possibility that selectiv-
ity in human HPC homing to BM may involve expression
of non–PSGL-1 E-selectin ligands, such as HCELL, on hu-
man HPC. In this regard, the fact that HCELL expression
is uniquely restricted to CD34  hematopoietic cells indi-
cates that this CD44 glycoform may impart specificity for
progenitor cell rolling on BM microvasculature. Interest-
ingly, though binding to HA could contribute to CD34 
rolling interactions on BM endothelium (DeGrendele et
al., 1996; Peled et al., 1999), the rather extensive distribu-
tion of CD44 among both immature and mature human
BM cells (Kansas et al., 1990) and the fact that human
CD34  cell rolling on endothelium is not inhibited by an-
tibodies that block binding to HA and is inhibited by che-
lation of divalent ions (which does not affect CD44–HA
binding) (Peled et al., 1999), indicates that CD44–HA in-
teractions are neither unique nor critical to HPC rolling on
BM endothelium. Other studies have provided various in-
dependent lines of evidence showing that CD44 may play
a role in HPC homing to BM (Khaldoyanidi et al., 1996;
Zoller et al., 1998), in tissue distribution of myeloid pro-
genitors (Schmits et al., 1997), and in engraftment of trans-
planted hematopoietic progenitor cells (Sandmaier et al.,
1990; Watanabe et al., 1998). Thus, whereas L-selectin is
operationally known as the “lymph node homing recep-
tor” and CLA is known as a “skin homing receptor,” the
data reported here are consistent with a role for HCELL
as a “bone marrow homing receptor.” Our findings ex-
pand the current knowledge of the structural biology of
E-selectin ligands, bestow a new perspective on ligands fa-
cilitating HPC trafficking to E-selectin-expressing tissueThe Journal of Cell Biology, Volume 153, 2001 1286
microvessel beds, and have broad implications exploiting
HCELL as a biological surrogate for positive selection of
HPCs with improved engraftment potential.
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